Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Conditions
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Interventions
- DRUG: Androgen Receptor Pathway Inhibitors (ARPIs)
Sponsor
Ankara Etlik City Hospital
Collaborators